SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

29 Mar 2012 12:56

RNS Number : 3714A
Caledonia Investments PLC
29 March 2012
Β 

ο»Ώ

Caledonia Investments plc

Director/PDMR Shareholding Notification

Β 

Caledonia Investments plc ("Caledonia") has been advised of the following transaction involving two of its directors, William Wyatt and The Honourable Charles Cayzer:-

Β 

On 29 March 2012, a family trust, of which Mr Wyatt and The Honourable Charles Cayzer are Trustees and of which Mr Wyatt is a potential beneficiary, distributed 18,505 Caledonia ordinary shares, representing 0.03% of Caledonia's total issued ordinary share capital, to beneficiaries of the trust unconnected with either director. The Caledonia shares held by the trust are included within the beneficial interests of Mr Wyatt and the non-beneficial interests of The Honourable Charles Cayzer.

Β 

This transaction is disclosed by Mr Wyatt and The Honourable Charles Cayzer in accordance with DTR 3.1.2R. All of the Caledonia shares distributed by the trust remain within the Cayzer family concert party and were registered in the name of Caytrust Finance Company Limited.

Β 

Mr Wyatt's total interests in Caledonia's ordinary shares following the above transaction are as follows:

Β 

Beneficial - 1,014,920* shares = 1.77%

Non-beneficial - 19,093 shares = 0.03%

Options - 103,929 shares = 0.18%

Deferred bonus plan - 8,470 shares = 0.01%

Performance share scheme awards - 37,682 = 0.07%

Β 

* 914,000 shares of Mr Wyatt's total beneficial holding are owned by The Dunchurch Lodge Stud Company, a company controlled by Mr Wyatt and certain of his connected persons.Β 

Β 

The Honourable Charles Cayzer's total interests in Caledonia's ordinary shares following the above transaction are as follows:

Β 

Beneficial - 40,892 shares = 0.07%

Non-beneficial - 23,985 shares = 0.04%

Options - 78,015 shares = 0.14%

Deferred bonus plan - 3,114 shares = 0.01%

Performance share scheme awards - 22,609 = 0.04%

Β 

Name of duly authorised officer of issuer responsible for making notification:

Β 

G P Denison

Company Secretary

Tel: +44 20 7802 8080

29 March 2012

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSSEIFFUFESEID
Date   Source Headline
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.